# Intelligent Implant Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intelligent-implant-systems

- Industry: Medical Devices & Equipment
- Headquarters: Charlotte, US
- Website: www.intelligentimplantsystems.com
- Total disclosed funding: $8.7M
- Latest round: Seed (Oct 23, 2021)
- Investors on record: 3

## About

Intelligent Implant Systems, LLC specializes in the development of advanced medical devices that enhance patient outcomes in orthopedic surgery through innovative implant technologies.Intelligent Implant Systems, LLC, founded in 2007 in Charlotte, US, focuses on the creation of medical devices for orthopedic surgery. The company has completed four deals to date, with its most recent funding occurring on October 23, 2021. This Seed round raised EUR 7.5 mn from investors including EIC Accelerator, HAX, and SOSV. CEO Marc Richelsoph leads the company, emphasizing its commitment to innovation in implant technology.Intelligent Implant Systems develops advanced medical devices aimed at improving patient outcomes in orthopedic surgery. Their innovative implant technologies promote better integration with biological tissues to reduce implant failure and postoperative complications. These products cater mainly to spinal and orthopedic surgeries, targeting hospitals, surgical centers, and clinics across North America and Europe, serving a diverse patient base including athletes and individuals with degenerative conditions.Revenue for Intelligent Implant Systems is generated through direct sales to healthcare institutions and surgical providers, with contracts established with hospitals and surgical centers to facilitate adoption of their technologies. The pricing structure includes bulk purchasing agreements, allowing healthcare providers to customize implant solutions based on patient needs, optimizing surgical outcomes.Intelligent Implant Systems plans to leverage its recent Seed funding of EUR 7.5 mn, raised in October 2021, to further develop and launch new products aimed at enhancing orthopedic surgery outcomes. The company is strategizing for expansion into new geographic markets in Europe and North America by 2025, focusing on increasing its footprint within hospitals and surgical centers. The investment will support R&D initiatives, aimed at bringing innovative solutions to market and addressing critical needs in the orthopedic sector.

## Funding rounds

- Seed, Oct 23, 2021, $8.7M — SOSV, HAX, State Street Digital
- Seed, Jan 19, 2017 — SOSV, HAX
- Seed, Jul 16, 2015 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- HAX — Seed
- State Street Digital (https://capitalatlas.ai/funds/state-street-digital) — Seed
